EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MRI Reflects Meningioma Biology and Molecular Risk

Julian Canisius iD, Julia Schuler iD, Maria Goldberg iD, Olivia Kertels, Marie-Christin Metz iD, Chiara Negwer iD, Igor Yakushev, Bernhard Meyer iD, Stephanie E Combs, Jan S Kirschke iD, Denise Bernhardt, Benedikt Wiestler iD und 1 weitere

Cancers · 15.11.2025 · 17 (22) · 3665

DOI: 10.3390/cancers17223665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 15.11.2025. Verfasst von Julian Canisius und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic and Interventional Neuroradiology, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, …. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Large-scale (epi)genomic studies have substantially advanced our understanding of the molecular landscape of meningiomas, most recently embedded in the cIMPACT-NOW update 8. As a result, molecular data are increasingly integrated into risk-adapted treatment algorithms. However, it remains uncertain to what extent non-invasive MRI can capture underlying molecular variation and risk.

Methods

We assembled a large, single-institution cohort of 225 newly diagnosed meningiomas (WHO grades 1–3) with available preoperative MRI, as well as comprehensive epigenome-wide methylation and copy-number profiling. Tumors were segmented into core and edema regions using a state-of-the-art automated pipeline from the BraTS challenge. Radiomic features were extracted and used to train Random Forest classifiers to predict WHO grade, molecular risk, and specific alterations such as 1p loss in a hold-out test set.

Results

Our models achieved accuracy above 91% for integrated molecular risk classification, 87.5% for 1p chromosomal status, and 76.8% for WHO grade prediction, with corresponding AUCs of 0.91, 0.90, and 0.89, underscoring the robustness of radiomic features in capturing histopathological and, especially, molecular characteristics.

Conclusions

Preoperative MRI effectively captures the underlying molecular biology of meningiomas and may enable rapid molecular assessment to inform decision-making and prioritization of confirmatory testing. However, it is not yet ready for clinical use, showing lower accuracy for current WHO grade classification.

Schlagwörter

Stichwörter der Autor:innen

DNA methylationcIMPACT-NOW update 8chromosome 1p statuscopy number variationmachine learningmagnetic resonance imagingmeningiomamolecular risk stratificationradiogenomicsradiomicstumor shape analysis

Autor:innen und Institutionen

  • Department of Diagnostic and Interventional Neuroradiology, Klinikum Rechts der Isar, School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
  • Institute of Pathology, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.
  • Department of Neurosurgery, Klinikum Rechts der Isar, School of Medicine and Health, University Hospital of TUM, 81675 Munich, Germany.
  • Department of Nuclear Medicine, School of Medicine, TUM University Hospital, Technical University of Munich, 81675 Munich, Germany.
  • Department of Radiation Oncology, TUM School of Medicine, TUM University Hospital Rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
  • AI for Image-Guided Diagnosis and Therapy, TUM School of Medicine and Health, Technical University of Munich, 81675 Munich, Germany.

ORCID-Profile: Julian Canisius, Julia Schuler, Maria Goldberg, Marie-Christin Metz, Chiara Negwer, Bernhard Meyer, Jan S Kirschke, Benedikt Wiestler, Claire Delbridge

Zitieren

APA

Canisius, J., Schuler, J., Goldberg, M., Kertels, O., Metz, M. C., Negwer, C., Yakushev, I., Meyer, B., Combs, S. E., Kirschke, J. S., Bernhardt, D., Wiestler, B., & Delbridge, C. (2025). MRI Reflects Meningioma Biology and Molecular Risk. Cancers, 17(22), 3665. https://doi.org/10.3390/cancers17223665

Vancouver

Canisius J, Schuler J, Goldberg M, Kertels O, Metz MC, Negwer C, et al. MRI Reflects Meningioma Biology and Molecular Risk. Cancers. 2025;17(22):3665. doi:10.3390/cancers17223665

BibTeX
@article{Canisius2025,
  author = {Canisius, Julian and Schuler, Julia and Goldberg, Maria and Kertels, Olivia and Metz, Marie-Christin and Negwer, Chiara and Yakushev, Igor and Meyer, Bernhard and Combs, Stephanie E and Kirschke, Jan S and Bernhardt, Denise and Wiestler, Benedikt and Delbridge, Claire},
  title = {MRI Reflects Meningioma Biology and Molecular Risk},
  journal = {Cancers},
  year = {2025},
  volume = {17},
  number = {22},
  pages = {3665},
  doi = {10.3390/cancers17223665}
}
Kostenlos starten →